Kevin J. Yeaman - 05 Feb 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
President and CEO, Director
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Issuer symbol
DLB
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
4
Filing time
09 Feb 2026, 16:19:17 UTC
Previous filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
YEAMAN KEVIN J President and CEO, Director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO /s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 09 Feb 2026 0001200469

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DLB Employee Stock Option (Right to Buy) Gift $0 -145,252 -50% $0.000000 145,252 05 Feb 2026 Class A Common Stock 145,252 $66.62 Direct F1, F2
transaction DLB Employee Stock Option (Right to Buy) Gift $0 +145,252 $0.000000 145,252 05 Feb 2026 Class A Common Stock 145,252 $66.62 By a trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.
F2 This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
F3 By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009